miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10
Aging · 2024
DOI: 10.18632/aging.205554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Xiaoye Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi Province, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi Province, China.
- Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi Province, China.
Zitieren
APA
Cheng, X., Wu, C., Xu, H., Zou, R., Li, T., & Ye, S. (2024). miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10. Aging. https://doi.org/10.18632/aging.205554
Vancouver
Cheng X, Wu C, Xu H, Zou R, Li T, Ye S. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10. Aging. 2024. doi:10.18632/aging.205554
BibTeX
@article{Cheng2024,
author = {Cheng, Xiaoye and Wu, Can and Xu, Haocheng and Zou, Ruixiang and Li, Taiyuan and Ye, Shanping},
title = {miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205554}
}
EUVIMED